iShares U.S. Pharmaceuticals ETF

NAV

$93.7

Expense ratio

0.38% / yr

Net assets

$970M

Holdings

55

How much hyper-growth does this ETF hold?

0% of holdings are StockRay S/AA hyper-growth grade.

ⓘ The ETF itself is not scored. This is the StockRay grade distribution of its holdings. Unrated means holdings outside our coverage (foreign stocks, new listings, etc.).